- Naloxone, sold under the brand name “Narcan”, works by attaching to the opioid receptors in the brain, almost immediately causing reversal of these circumstances.
- May be administered via intramuscular injection or nasal spray.
- Naloxone has been included in the standing orders for Mobile Intensive Care Units in the state and is administered by crewmembers in the event of a suspected overdose.
- The law allows for distribution of naloxone to individuals at-risk of opioid overdose and to “members of their families or peers,” by redefining “patient” to include a person
- who is not at risk of an opioid overdose . . .
- who, in the judgment of a physician, may be in a position to assist another individual during an overdose and
- who has received patient overdose information…on the indications for and administration of an opioid antidote. N.J.S.A. 24:6J-3
- Physicians are authorized to prescribe to those who are not expected to be the end-user, so long as they might be in a “position to assist” and have received “patient overdose information”.